SDMA is an early marker of change in GFR after living-related kidney donation

Nephrology Dialysis Transplantation

Volumn 26, Issue 1, 2011, Pages 324-328

  Kielstein, Jan T ^a   Veldink, Hendrik ^a   Martens Lobenhoffer, Jens ^b   Haller, Hermann ^a   Burg, Michael ^c   Lorenzen, Johan M ^a   Lichtinghagen, Ralf ^a   Bode Böger, Stefanie M ^b   Kliem, Volker ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c Nephrological Centre Lower Saxony   (Germany)

Author keywords

acute kidney injury; ADMA; renal function; transplantation

Indexed keywords

6 N,N' DIMETHYLARGININE; CREATININE; CYSTATIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DONOR; LIVING DONOR; MALE; PRIORITY JOURNAL; UNINEPHRECTOMY;

ACUTE KIDNEY INJURY; ARGININE; BIOLOGICAL MARKERS; CREATININE; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEPHRECTOMY; PROGNOSIS; SURVIVAL RATE;

EID: 77957240598     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq395     Document Type: Article

References (28)

1. Centre for Disease Control. Hospitalization discharge diagnoses for kidney disease-United States, 1980-2005. MMWR 2008, 57, 309-312.
2. Herget-Rosenthal S, Pietruck F, Volbracht L et al. Serum cystatin C- a superior marker of rapidly reduced glomerular filtration after unin-ephrectomy in kidney donors compared to creatinine. Clin Nephrol 2005; 64: 41-46
3. Haase-Fielitz A, Bellomo R, Devarajan P et al. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery-a prospective cohort study. Crit Care Med 2009; 37: 553-560
4. Goonasekera CD, Rees DD, Woolard P et al. Nitric oxide synthase inhibitors and hypertension in children and adolescents. J Hypertens 1997; 15: 901-909
5. Kielstein JT, Salpeter SR, Bode-Boeger SM et al. Symmetric di-methylarginine (SDMA) as endogenous marker of renal function- a meta-analysis. Nephrol Dial Transplant 2006; 21: 2446-2451
6. Kielstein JT, Martens-Lobenhoffer J, Vollmer S et al. L-Arginine, ADMA, SDMA, creatinine, MDRD formula-detour to renal function testing. J Nephrol 2008; 21: 963-965
7. Kielstein JT, Fliser D, Veldink H. Asymmetric dimethylarginine and symmetric dimethylarginine: axis of evil or useful alliance? Semin Dial 2009; 22: 346-350
8. Carello KA, Whitesall SE, Lloyd MC et al. Asymmetrical dimethy-larginine plasma clearance persists after acute total nephrectomy in rats. Am J Physiol Heart Circ Physiol 2006; 290: H209-H216
9. Martens-Lobenhoffer J, Bode-Boger SM. Fast and efficient determination of arginine, symmetric dimethylarginine, and asymmetric di-methylarginine in biological fluids by hydrophilic-interaction liquid chromatography-tandem mass spectrometry. Clin Chem 2006; 52: 488-493
10. Vallance P, Leiper J. Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 2004; 24: 1023-1030
11. Kakimoto Y, Akazawa S. Isolation and identification of N-G, N-G- and N-G, N'-G-dimethyl-arginine, N-epsilon-mono-, di-, and trimethylly-sine, and glucosylgalactosyl- and galactosyl-delta-hydroxylysine from human urine. J Biol Chem 1970; 245: 5751-5758
12. Nijveldt RJ, van Leeuwen PA, van Guldener C et al. Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans. Nephrol Dial Transplant 2002; 17: 1999-2002
13. Bjarnadottir M, Grubb A, Olafsson I. Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. Scand J Clin Lab Invest 1995; 55: 617-623
14. Risch L, Herklotz R, Blumberg A et al. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 2001; 47: 2055-2059
15. Uchida HA, Nakamura Y, Kaihara M et al. Steroid pulse therapy impaired endothelial function while increasing plasma high molecule adiponectin concentration in patients with IgA nephropathy. Nephrol Dial Transplant 2006; 21: 3475-3480
16. Zoccali C, Maas R, Cutrupi S et al. Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections. Nephrol Dial Transplant 2007; 22: 801-806
17. Rule AD, Bergstralh EJ, Slezak JM et al. Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int 2006; 69: 399-405
18. Billecke SS, D'Alecy LG, Platel R et al. Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease. Nephrol Dial Transplant 2009; 24: 489-496
19. Bode-Boger SM, Scalera F, Kielstein JT et al. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. J Am Soc Nephrol 2006; 17: 1128-1134
20. Schepers E, Glorieux G, Dhondt A et al. Role of symmetric dimethy-larginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes. Nephrol Dial Transplant 2009; 24: 1429-1435
21. Herget-Rosenthal S, Poppen D, Husing J et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004; 50: 552-558
22. Herget-Rosenthal S, Marggraf G, Husing J et al. Early detection of acute renal failure by serum cystatin C.Kidney Int 2004; 66: 1115-1122
23. Hirsch R, Dent C, Pfriem H et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 2007; 22: 2089-2095
24. Ahlstrom A, Tallgren M, Peltonen S et al. Evolution and predictive power of serum cystatin C in acute renal failure. Clin Nephrol 2004; 62: 344-350
25. Song S, Meyer M, Turk TR et al. Serum cystatin C in mouse models: a reliable and precise marker for renal function and superior to serum creatinine. Nephrol Dial Transplant 2009; 24: 1157-1161
26. Shemesh O, Golbetz H, Kriss JP et al. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985; 28: 830-838
27. Najarian JS, Chavers BM, McHugh LE et al. 20 year follow-up of living kidney donors. Lancet 1992; 340: 207-210
28. Manolio T. Novel risk markers and clinical practice. N Engl J Med 2003; 349: 1587-1589